Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Midday movers: Walt Disney, Lockheed Martin, Exxon Mobil and more

Published 09/10/2023, 18:17
© Reuters.
CVX
-
C
-
DIS
-
NOC
-
LMT
-
XOM
-
BMY
-
DAL
-
UAL
-
AAL
-
SPOT
-

Investing.com -- U.S. stocks are falling on Monday over worries about the intensifying conflict between Israel and Hamas. A week of inflation data and big bank earnings lie ahead.

Here are some of the biggest U.S. stock movers today:

  • Walt Disney (NYSE:DIS) stock rose 1.4% after reports that Nelson Peltz's Trian Fund Management has increased its stake in the entertainment giant and the activist investor is expected to request multiple board seats, including for himself.

  • Lockheed Martin (NYSE:LMT) stock rose 8%, Northrop Grumman (NYSE:NOC) stock rose 10.8% and RTX (NYSE:RTX) stock rose 4.6% as these defense stocks gain on the expectation of increased spending given the increased geopolitical tension.
  • Exxon Mobil (NYSE:XOM) stock rose 2.9% and Chevron (NYSE:CVX) stock rose 2.6% after oil prices surged as the escalated conflict in the Middle East raised concerns about future global supply.
  • Citigroup (NYSE:C) stock fell 0.8% after the banking giant agreed to sell its retail wealth management portfolio in mainland China to HSBC (LON:HSBA) (NYSE:HSBC), down 2.3%.

  • United Airlines (NASDAQ:UAL) stock fell 5%, American Airlines (NASDAQ:AAL) stock fell 4.7% and Delta Air Lines (NYSE:DAL) stock dropped 4.5%, with several airlines having halted or reined in some flights to Israel following the escalation of violence between the country's forces and Palestinian group Hamas.

  • Spotify (NYSE:SPOT) stock fell 2.5% after Redburn-Atlantic downgraded its stance on the audio streaming service to ‘neutral’ from ‘buy’, estimating the company’s new audiobook offer will be gross margin dilutive.

  • Bristol-Myers Squibb (NYSE:BMY) stock fell 0.8% after the pharmaceutical company said it will acquire cancer drugmaker Mirati Therapeutics (NASDAQ:MRTX), down 4.6%, for up to $5.8 billion, diversifying its oncology business.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.